FindTrial
Sign In

Physicochemical and Clinical study of Syrup Bal Ayush Kwath effect on common disease occurence among children.

Physicochemical and Clinical evaluation of Syrup Bal Ayush Kwath effect on common morbidity occurence among children - A randomized controlled clinical trial.

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048470
Enrollment
150
Registered
2022-12-26
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age 5 -10 year of both sex. 2.Pediatric subjects will be selected irrespective of the socioeconomic status. 3.Those who are willing to participate in the study. 4.Written informed assent/consent will be documented

Exclusion criteria

Exclusion criteria: 1.Suffering from any systemic illness and infectious disease, Severe malnutrition, Autoimmune disorders, immunodeficiency disorders. 2.Those who are unable for regular follow up. 3.Known allergy to any content of Syrup Bal Ayush Kwath.

Design outcomes

Primary

MeasureTime frame
Reducing common morbidity occurrence.Timepoint: 0th day,30th day,60th day,90th day and follow up—

Secondary

MeasureTime frame
1.Physicochemical Characterization and Validation of possible bioactives of Syrup Bal Ayush Kwath, and Drug Standardization using HPTLC and LCMS-MS. 2.Searching interaction between phytoconstituent and target protein. Inhibition and induction of phytoconstituents for selected proteins/receptors through molecular docking and molecular dynamics. 3.Network pharmacology, gene target disease predictions (computational) study of Syrup Bal Ayush Kwath specific to respiratory and Gastrointestinal system centric symptoms. 4.Improvement in anthropometric measures among pediatric age group.Timepoint: LCMS HR-1 Month Network Pharmacology-2 Month Molecular docking and dynamics-1 Month Anthropometric measures-0th day and 90th day—

Countries

India

Contacts

Public ContactDr Prashant Kumar Gupta

All India Institute of Ayurveda

prashantgupta27@gmail.com9990988860

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026